TIGIT overexpression in CD8+ and CD4+ T cells is correlated with HNSCC progression and a poor treatment response, and TIGIT/PD-1/LAG-3 axis activation is correlated with tumor progression and the development of an immunosuppressive microenvironment [119]. Here, TIGIT is linked to neoplasm.